Larry Ellberger, Director at Celldex Therapeutics, Inc. (CLDX), bought 5,000 shares at $16.59 ($83K) on 2015-08-13, disclosed to the SEC on 2015-08-14.
Open-market purchase of $83k CLDX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CLDX | BUY | 2015-08-19 | $80K | — | Filing → |
| CLDX | SELL | 2013-12-10 | $434K | — | Filing → |
| CLDX | BUY | 2009-11-30 | $45K | — | Filing → |